On the other hand, the biologically active carboxy-terminal peptide (BNP 1–22), derived from the cleavage of the proBNP precursor by both furin and corin [13], appears to have a weaker impact on the pathogenesis of hypertension compared to ANP at the experimental level. This evidence concerns the gene FURIN and hypertensive disorder.